Prevalence and incidence of pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) in Belgium; developing detection methods of preclinical PAH; and influencing clinical outcome by early treatment of pulmonary vascular disease. KU Leuven
Pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) implicates considerable morbidity and mortality. Through the unique Belgian Registry on Adult CHD, we first want to identify the prevalence and incidence of PAH in CHD. Also predictors of the development of PAH and long-term outcome will be defined.
Secondly, we would like to track these CHD patients who were discharged from follow-up in the ...